[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Hospital Clinico Universitario de Santiago\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":246},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,52,83,110,134,161,191,220],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":32,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":46,"leadSponsor":48,"locationsCount":51},"100631035","video-versus-direct-laryngoscopy-for-tracheal-intubation-in-pediatric-surgery-100631035",false,"NCT07495436","Video Versus Direct Laryngoscopy for Tracheal Intubation in Pediatric Surgery","Videolaryngoscopy Versus Direct Laryngoscopy for Tracheal Intubation in Pediatric Surgery: The VIDEOKIDS Pragmatic Multicentre Randomized Trial","VIDEOKIDS","Inclusion Criteria:\n\n* Paediatric patients (age 0-16 years),\n* Undergoing elective or scheduled surgery under general anaesthesia requiring orotracheal intubation,\n* Planned tracheal intubation using either videolaryngoscopy or direct laryngoscopy as the initial technique,\n* Informed or general consent given, according to the relevant ethics committee statement,.\n\nExclusion Criteria:\n\n* Known upper airway anatomical abnormalities or clinical conditions requiring a specific intubation technique (e.g., fibreoptic intubation),\n* Requirement for emergent tracheal intubation that does not allow adequate randomisation,\n* Refusal of parents or legal guardians to participate in the study.","ALL","0 Days","16 Hours",{"count":21,"type":22},5562,"ESTIMATED","INTERVENTIONAL",[25],"NA","Tracheal intubation in paediatric patients is a high-risk procedure in which failure to achieve successful intubation on the first attempt is associated with an increased risk of complications, including hypoxaemia and airway trauma. Videolaryngoscopes have been increasingly adopted in clinical practice because they improve glottic visualisation; however, evidence of their benefit in paediatric patients remains inconsistent.\n\nThe VIDEOKIDS trial is a large, pragmatic, international, multicentre, randomised controlled trial designed to compare videolaryngoscopy with direct laryngoscopy as the initial technique for tracheal intubation in paediatric patients undergoing surgery under general anaesthesia. The primary objective is to determine whether videolaryngoscopy increases the rate of successful intubation on the first attempt compared with direct laryngoscopy.",[28,29,30,31],"Tracheal Intubation","Videolaryngoscopy","General Anesthesia","Difficult Airway Intubation",[33,34,35,36,37,38],"tracheal intubation","videolaryngoscopy","laryngoscopy","Paediatric airway","Airway management","Randomised controlled trial","NOT_YET_RECRUITING","2026-04-17",{"date":42,"type":43},"2026-04-22","ACTUAL",{"date":45,"type":22},"2026-05-01",{"date":47,"type":22},"2027-12-30",{"name":49,"class":50},"Hospital Clinico Universitario de Santiago","OTHER",1,{"id":53,"slug":54,"hasResults":11,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":11,"sex":17,"minAge":60,"maxAge":61,"enrollmentInfo":62,"targetDuration":4,"studyType":23,"phases":64,"briefSummary":65,"conditions":66,"keywords":71,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},"100540889","hyperangulated-vs-macintosh-blades-for-intubation-with-videolaryngoscopy-in-icu-100540889","NCT06322719","Hyperangulated vs Macintosh Blades for Intubation With Videolaryngoscopy in ICU","A Randomized Comparison Between the Hyperangulated vs. Macintosh Blades for First-attempt Intubation Success With Videolaryngoscopy in ICU Patients.","INVIBLADE","Inclusion Criteria:\n\n* Age 18 years or older.\n* Admitted to an Intensive Care Unit.\n* Need for tracheal intubation during the stay in the ICU.\n* The device to be used for intubation is a videolaryngoscope\n\nExclusion Criteria:\n\n* Pregnancy or lactation.\n* Emergent tracheal intubation that does not allow for the randomization of the procedure.\n* Need for tracheal intubation with a device other than the videolaryngoscope (fiberoptic bronchoscope, direct laryngoscopy, tracheostomy, etc.).\n* Tracheal intubation performed outside the ICU (Emergency Department, Hospital ward, etc.).","18 Years","90 Years",{"count":63,"type":22},1036,[25],"Tracheal intubation in the intensive care unit (ICU) is associated with high incidence of difficult intubation and complications. Videolaryngoscopes (VLs) devices have been proposed to improve airway management, and the use of VLs are recommended as first-line or after a first-attempt failure using direct laryngoscopy in ICU airway management algorithms. Although until relatively few years ago there were doubts about whether videolaryngoscopes had advantages over direct laryngoscopy for endotracheal intubation (ETI) in critically ill patients, two recent studies (DEVICE (1), INTUBATE (2)), and a Cochrane review (3) have confirmed that videolaryn should be used?, and what is the best blade? . There are two types of blades commonly used with videolaryngoscopes: the \"Macintosh\" blade with a slight curvature, and hyperangulated blades. The \"Macintosh\" blades have a lower angle of vision, but they have the advantage of being similar to the blades commonly used in direct laryngoscopy, making them easy to use for the person performing the ETI. Hyperangulated blades have a greater angle of vision, improving glottic visualization, especially in patients with an anterior glottis. However, the need to overcome this angulation could potentially hinder the passage of the endotracheal tube to the vocal cords. It is unknown if either blade has any advantage for intubating critically ill patients.",[67,68,69,29,70],"Acute Respiratory Failure","Intubation","Intubation; Difficult or Failed","Intubation Complication",[34,33,72],"complication","RECRUITING","2025-09-09",{"date":76,"type":43},"2025-09-15",{"date":78,"type":43},"2024-05-01",{"date":80,"type":22},"2026-06-01",{"name":49,"class":50},29,{"id":84,"slug":85,"hasResults":11,"nctId":86,"briefTitle":87,"officialTitle":88,"acronym":89,"eligibilityCriteria":90,"healthyVolunteers":11,"sex":17,"minAge":60,"maxAge":91,"enrollmentInfo":92,"targetDuration":4,"studyType":23,"phases":94,"briefSummary":95,"conditions":96,"keywords":99,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":103,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":109},"100471255","c-mac-videolaryngoscopy-versus-direct-laryngoscopy-for-percutaneous-tracheostomy-100471255","NCT05416489","C-MAC Videolaryngoscopy Versus Direct Laryngoscopy for Percutaneous Tracheostomy","Videolaryngoscopy Versus Direct Laryngoscopy for Positioning the Tracheal Tube During Percutaneous Tracheostomy: A Randomized Controlled Trial (VIDLARTRAQUEO).","VIDLARTRAQ","Inclusion Criteria:\n\n* ICU intubated patients that require a percutaneous dilational tracheostomy for clinical reasons (prolonged mechanical ventilation, airway protection or weaning failure).\n\nExclusion Criteria:\n\n* Patients younger than 18 years and older than 85 years\n* Trachea and neck abnormalities.\n* Soft tissue infection in the neck.\n* History of neck surgery.\n* Coagulation disorders or changes in coagulation parameters (platelet count \\\u003C 50.000 mm3, an activated partial thromboplastin time 1.5-fold longer than the control value, and international normalized ratio \\> 1.5).\n* Consent refusal for participating in the trial.","85 Years",{"count":93,"type":22},90,[25],"When preparing an ICU patient for percutaneous dilational tracheostomy, correct positioning of the endotracheal tube is important. During the procedure, it is possible to puncture the cuff. Tracheal tube cuff puncture can lead to failure of ventilation, loss of positive end-expiratory pressure, and possible aspiration of gastric contents blood or secretions. To minimize the risk, in our ICU, we withdraw the endotracheal tube under direct laryngoscopic vision until the cuff is visible at the vocal cords. This maneuver would also facilitate insertion of the Seldinger needle and insertion of the tracheostomy tube below the endotracheal tube. However, this maneuver to remove the endotracheal tube under direct laryngoscopy can sometimes be difficult. ICU patients present frecuently difficult laryngoscopic vision due to airway edema or secretions. In ICU, the videolaryngopy has been shown to be superior to direct laryngoscopy in visualization the upper airway, allowing better laryngoscopic vision.",[97,98],"Intubated Patients","Percutaneous Tracheostomy",[100,101,29,102,37],"Tracheostomy","Critical care","Direct laryngoscopy",{"date":76,"type":43},{"date":105,"type":43},"2022-01-01",{"date":107,"type":22},"2026-06-30",{"name":49,"class":50},2,{"id":111,"slug":112,"hasResults":11,"nctId":113,"briefTitle":114,"officialTitle":115,"acronym":116,"eligibilityCriteria":117,"healthyVolunteers":11,"sex":17,"minAge":60,"maxAge":4,"enrollmentInfo":118,"targetDuration":4,"studyType":23,"phases":120,"briefSummary":122,"conditions":123,"keywords":4,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":125,"lastUpdatePostDateStruct":126,"startDateStruct":128,"completionDateStruct":130,"leadSponsor":132,"locationsCount":133},"100523701","phase-4-efficacy-of-pert-for-pei-in-unresectable-pancreatic-cancer-100523701","NCT06099119","Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.","Open Label Randomized, Multicentre, Controlled Trial of Pancreatic Enzyme Replacement Therapy (PERT) for Pancreatic Exocrine Insufficiency (PEI) in Patients With Unresectable Pancreatic Cancer. The PERTseverance Trial.","PERTseverance","Inclusion Criteria:\n\n1. Pathologically confirmed unresectable, locally advanced or metastatic, pancreatic cancer.\n2. Tumour located in the head of the pancreas.\n3. Dilated main pancreatic duct confirmed by imaging methods (CT scan, MRI and\u002For EUS).\n4. Significant weight loss (≥5% of the usual body weight) at screening.\n5. Life expectancy of at least six months at screening.\n6. Signed informed consent to the study.\n\nExclusion Criteria:\n\n1. Hypersensitivity to pancreatin of porcine origin or to any of the excipients.\n2. Patients on neoadjuvant therapy, or in whom neoadjuvant therapy is planned.\n3. Patients already on PERT.\n4. Prior history of upper gastrointestinal or pancreatic surgery.\n5. Short life expectancy (shorter than 6 months).\n6. Patients on second line or beyond chemotherapy (those who failed with first line chemotherapy therapy).\n7. Patients in whom a pancreatic stent has been placed.\n8. Unsolved gastric outlet obstruction.\n9. Unwillingness to participate in the study.\n10. Inability to comply with the study visits and study protocol, whatever the reason.",{"count":119,"type":22},100,[121],"PHASE4","\\- This will a be an open label, multicentre, randomized, controlled study in patients with unresectable pancreatic cancer, locally advanced or metastatic, with significant weight loss, and the tumour located in the head of the pancreas associated with dilated main pancreatic duct. Pancreatic Exocrine Replacement Therapy (PERT) in these patients will be given on top of other required therapies (best standard of care, BSC), including oncologic therapies, diabetes mellitus therapies and acid suppressants and nutritional support as appropriate. The duration of the study will be up to six months.\n\nConsecutive patients meeting inclusion criteria and none of the exclusion criteria will be evaluated for the study. Those patients signing the informed consent for study participation will be randomized to one of the following two arms:\n\n* The experimental arm will receive the best standard of care (BSC) and PERT (capsules containing pancreatin 35,000 Ph.U.) at a fixed dose of 3 capsules with main meals (breakfast, lunch and dinner) and 2 capsules with snacks over 6 months.\n* The control arm will receive the BSC over 3 months, followed by a further 3-month open uncontrolled phase of BSC + PERT at the dose mentioned above.\n\nAll patients will receive in addition a proton pump inhibitor (PPI) bid (any PPI at standard dose is acceptable -omeprazole 20 mg, lansoprazole 30 mg, pantoprazole 40 mg, rabeprazole 20 mg, esomeprazole 40 mg) while on PERT, 20-30 minutes before breakfast and dinner.\n\nTo make the two arms comparable, patients will be stratified in two groups (locally advanced and metastatic pancreatic cancer) for randomization using computer generated random numbers.",[124],"Unresectable Pancreatic Cancer","2025-06-03",{"date":127,"type":43},"2025-06-06",{"date":129,"type":43},"2024-02-20",{"date":131,"type":22},"2026-12",{"name":49,"class":50},4,{"id":135,"slug":136,"hasResults":11,"nctId":137,"briefTitle":138,"officialTitle":139,"acronym":140,"eligibilityCriteria":141,"healthyVolunteers":11,"sex":17,"minAge":60,"maxAge":61,"enrollmentInfo":142,"targetDuration":4,"studyType":23,"phases":144,"briefSummary":145,"conditions":146,"keywords":147,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":153,"lastUpdatePostDateStruct":154,"startDateStruct":156,"completionDateStruct":158,"leadSponsor":160,"locationsCount":51},"100472226","flexible-tip-bougie-vs-tube-with-stylet-for-intubation-with-videolaryngoscopy-100472226","NCT05429125","Flexible Tip Bougie vs Tube With Stylet for Intubation With Videolaryngoscopy.","A Randomized Comparison Between the Flexible Tip Bougie vs Tube With Stylet for First-attempt Intubation Success With the C-MAC Videolaryngoscopy in Patients With Anticipated Difficult Airway","VIFLEXTIPOR","Inclusion Criteria:\n\n* 18 years and older\n* Patients with anticipated difficult airway requiring intubation under with a videolaryngoscopy\n* Written informed consent from the patient or proxy (if present) before inclusion or once possible when patient has been included in a context of emergency.\n\nExclusion Criteria:\n\n* Pregnancy\n* age \\\u003C18 years\n* refusal of the patient\n* patient's respiratory failure",{"count":143,"type":22},140,[25],"Although VLs improve glottic visualization, on many occasions it may not be accompanied by intubation at the first attempt, because the endotracheal tube has to pass a sharp angle to enter the trachea. To avoid this limitation, a new flexible tip bougie is designed to flexibly navigate the distal tip and help facilitate precise insertion of the endotracheal tube in the trachea. The flexible tip bougie has an integrated slider along the surface which moves the tip anterior and posterior while the pre-curved distal portion of shaft allows the angulation to provide anterior flexion. This new flexible tip bougie could be used as a rescue when first intubation failure using the videolaryngoscopy, or as a first option to improve the percentage of patients intubated at the first attempt.",[69],[148,149,150,151,152],"intubation","difficult airway","videolaryngoscope","operating room","Awake intubation","2024-12-29",{"date":155,"type":43},"2024-12-31",{"date":157,"type":43},"2022-06-17",{"date":159,"type":22},"2025-12-31",{"name":49,"class":50},{"id":162,"slug":163,"hasResults":11,"nctId":164,"briefTitle":165,"officialTitle":166,"acronym":4,"eligibilityCriteria":167,"healthyVolunteers":11,"sex":17,"minAge":60,"maxAge":168,"enrollmentInfo":169,"targetDuration":4,"studyType":23,"phases":171,"briefSummary":172,"conditions":173,"keywords":176,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":183,"lastUpdatePostDateStruct":184,"startDateStruct":186,"completionDateStruct":188,"leadSponsor":190,"locationsCount":51},"100571877","personalized-treatment-of-refractory-bppv-100571877","NCT06725966","Personalized Treatment of Refractory BPPV","Personalized Medicine to Treat Refractory Benign Paroxysmal Positional Vertigo, Through Computational Fluid Dynamics Analysis From Magnetic Resonance Image Reconstructions","Inclusion Criteria:\n\n* A. Diagnosed with BPPVp according to the Barany Society criteria:\n\n  1. Recurrent episodes of vertigo or positional instability, triggered by lying down or turning the head in the supine position.\n  2. Episodes lasting less than 1 minute.\n  3. Positional nystagmus observed after a latency period during the Dix-Hallpike test (DHT), with an upward vertical component and a torsional component (clockwise on the left side and counterclockwise on the right).\n  4. Symptoms not explained by any other cause.\n\n     AND\n* B. Refractory to otolith repositioning maneuvers (Epley and\u002For Semont maneuvers), with persistence of symptoms after three attempts.\n\nExclusion Criteria:\n\n* Cognitive impairment that prevents understanding of their condition and the required procedures.\n* Pathological conditions that hinder the execution of the maneuvers.\n* BPPV involving canals other than the posterior canal or bilateral posterior canal involvement.\n* Low educational level, which may impede understanding of the procedures and informed consent.","100 Years",{"count":170,"type":22},54,[25],"Background: Benign paroxysmal positional vertigo (BPPV) is the most common cause of vertigo, often effectively treated with standard canalith repositioning maneuvers (CRMs). However, approximately 12.5% of cases remain refractory, leading to persistent symptoms and increased healthcare burden. Variations in the anatomical orientation of the semicircular canals (SCCs) may explain the resistance to conventional maneuvers. This study explores a personalized medicine approach, utilizing computational fluid dynamics (CFD) based on MRI reconstructions to tailor CRMs with the help of mechanical rotation chair according to individual inner ear anatomy.\n\nMethods: The investigators conducted a randomized, multicenter, open-label study targeting patients with refractory posterior canal BPPV. Participants were allocated to either a control group (receiving repeated standard CRMs and Brandt-Daroff exercises) or an intervention group (receiving personalized CRMs based on CFD simulations derived from MRI scans). The intervention group's maneuvers were executed using a mechanical rotational chair designed for precise angulation. Primary outcomes included resolution of nystagmus and vertigo symptoms, while secondary outcomes measured the reduction in healthcare visits and improved quality of life (Dizziness Handicap Inventory score).",[174,175],"Benign Paroxysmal Positional Vertigo","Personalized Medicine",[177,178,179,180,181,182],"BPPV","Benign paroxysmal positional vertigo","Computational fluid dynamics","MRI","Canalith repositioning maneuvers","Mechanical rotation chair","2024-12-08",{"date":185,"type":43},"2024-12-10",{"date":187,"type":43},"2024-07-01",{"date":189,"type":22},"2026-12-31",{"name":49,"class":50},{"id":192,"slug":193,"hasResults":11,"nctId":194,"briefTitle":195,"officialTitle":196,"acronym":197,"eligibilityCriteria":198,"healthyVolunteers":11,"sex":17,"minAge":60,"maxAge":199,"enrollmentInfo":200,"targetDuration":202,"studyType":203,"phases":4,"briefSummary":204,"conditions":205,"keywords":210,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":212,"lastUpdatePostDateStruct":213,"startDateStruct":215,"completionDateStruct":217,"leadSponsor":219,"locationsCount":51},"100539345","cardio-oncology-rehabilitation-care-process-100539345","NCT06302634","Cardio-Oncology Rehabilitation Care Process","Hospital-based Cardio-Oncology Rehabilitation Care Process for Cardiovascular Health in Cancer Patients","ReCO","Inclusion Criteria:\n\n* High risk of cancer treatment-related cardiotoxicity\n* Possibility of completing a cardio-onco rehabilitation program (centre-based or home-based) and programmed visits.\n* Providing written informed consent.\n\nExclusion Criteria:\n\n* Patients with physical or mental limitation to carry out an exercise program.","70 Years",{"count":201,"type":22},300,"9 Months","OBSERVATIONAL","The objective of this observational study is to assess the outcomes of a hospital-based Cardio-Oncology Rehabilitation (CORe) program focused on exercise in cancer patients undergoing cardiotoxic treatment. This evaluation will be conducted by analyzing disease-related health indicators, functional capacity, and quality of life. Patients at risk of cardiotoxicity attending the Cardio-Onco-Hematology Unit will be offered the exercise program, which includes two modalities: in-person (center-based) and remote (home-based) options. The assignment to either modality is non randomized, based on the functional assessment conducted in the Rehabilitation Unit and the agreement between healthcare professional and patient. All participants will perform a 3-month supervised exercise intervention. There are 3 time points for assessment: at baseline (T0), 3-month after the exercise program (T1) and follow-up at 9 months from baseline (T2).",[206,207,208,209],"Cardio-Oncology","Rehabilitation","Cardiovascular Diseases","Exercise",[211],"cardio-oncology rehabilitation; cardiovascular prevention; exercise; cancer","2024-03-13",{"date":214,"type":43},"2024-03-15",{"date":216,"type":43},"2022-06-22",{"date":218,"type":22},"2027-06-22",{"name":49,"class":50},{"id":221,"slug":222,"hasResults":11,"nctId":223,"briefTitle":224,"officialTitle":224,"acronym":225,"eligibilityCriteria":226,"healthyVolunteers":11,"sex":17,"minAge":60,"maxAge":227,"enrollmentInfo":228,"targetDuration":230,"studyType":203,"phases":4,"briefSummary":231,"conditions":232,"keywords":236,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":238,"lastUpdatePostDateStruct":239,"startDateStruct":241,"completionDateStruct":243,"leadSponsor":245,"locationsCount":51},"100538067","prevalence-and-impact-of-pertussis-and-rsv-on-asthma-severity-and-control-100538067","NCT06286007","Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control","PRIPASCO","Inclusion Criteria:\n\n* Adult patient (age 18 years and over)\n* Diagnosed with asthma at least one year prior to the date of enrolment.\n* Patients who, in the opinion of the investigator, can and will comply with the requirements of the study protocol for the duration of the follow-up period (e.g. agree to provide samples for testing, able to attend for testing upon asthma exacerbation and\u002For ARI symptoms occurring)\n* Patients who are able to provide written informed consent.\n\nExclusion Criteria:\n\n* Patients with a prior history of pertussis in the last 12 months\n* Patients with ARI within the 2 weeks prior to enrolment\n* Patients who have another respiratory disease other than asthma, alcohol or drug abuse at the time of being included in the study, or an active oncological disease (patients in treatment or follow-up for oncological disease) or pregnant women.\n* Patients treated with immunosuppressive or immunomodulating agents not related to asthma diagnosis. will be excluded.\n* Patients vaccinated for RSV will be also excluded (NOTE: -Patients that have received an RSV (investigational) vaccine or medicine for any of the above, should be excluded from the study from the beginning. Patients that might be vaccinated in the upcoming years, while the study is still ongoing, can enrol. However, from the moment they receive a vaccine, they should be excluded and no additional data will be collected. Data collected during the study up until the time of vaccination will still be included in the analysis).\n* Patients vaccinated for B. Pertussis during the previous 12 months will be also excluded.\n* Patients who plan to move during the study period will be excluded.","99 Years",{"count":229,"type":22},784,"2 Years","The main objective is to estimate the annual symptomatic incidence of Bordetella pertussis and RSV infections in patients aged 18 years and over with asthma, which will be identified by PCR, for Bordetella pertussis and by PCR for RSV performed at a specific timepoint from onset of symptoms for each symptomatic Acute Respiratory Infection (ARI).\n\nA multicentre prospective cohort study will be undertaken in Spain. Thirty-five centres from different autonomous communities in Spain will participate in the study.\n\nParticipants will be asked to report to the investigator if they experience an asthma exacerbation or symptoms of acute respiratory infection with 2 years follow up",[233,234,235],"Asthma","Pertussis","RSV Infection",[233,234,235,237],"Exacerbations","2024-02-29",{"date":240,"type":43},"2024-03-01",{"date":242,"type":43},"2023-12-21",{"date":244,"type":22},"2026-07-01",{"name":49,"class":50},""]